Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Jin Chen, PhD transferred to Julie Rhoades

Vanderbilt University Medical Center

Presented by METAvivor Facebook Fundraisers in honor of all people living with MBC

Targeting EphA2 receptor in breast-to-bone metastasis

Changyan Chen, PhD

Northeastern University

Presented by METAvivor Facebook Fundraisers in honor of all people living with MBC

Targeting MGL for Developing Novel Strategy to Treat Refractory Breast Cancer

Mathew Cherian, MD

The Ohio State University Comprehensive Cancer Center

Presented by the The Meadowbrook Country Club Rally For The Cure Fundraiser in memory of Elizabeth Stevens

Sulfatase 2 inhibition to intensify chemotherapy and immunotherapy responses in metastatic triple-negative breast cancer

Nir Ben Chetrit, PhD

Weill Medical College of Cornell University

#LightUpMBC Ambassador Team in Honor of Caitlin Blake

Harnessing Innate Immunity and Radiotherapy for Next-Generation Immuno-Oncology in Metastatic Breast Cancer

Jessica Christenson, PhD

University of Colorado Anschutz Medical Campus

Presented by Metavivor Facebook Fundraisers

Repurposing Lung Microenvironment Targeted Therapies for the Treatment of Established Breast Cancer Lung Metastases

DIANA CITTELLY, PhD

University of Colorado Anschutz Medical Campus

Targeting BDNF/TrkB in Brain Metastasis from Young Women with TNBC

Amanda Clark, PhD

University of Pittsburgh

Presented by Northwest Arkansas Metsquerade, Runway for Research

Extracellular vesicles regulate metastatic breast cancer dormancy in the liver

CHARLES CLEVENGER, MD, PhD

Virginia Commonwealth University

Inhibition of breast cancer metastatic outgrowth with non-immunosuppressive cyclosporine

Katherine Cook, PhD

Wake Forest University School of Medicine

Presented by Lake Norman Metsquerade in memory of Hilary Blake Hamilton

Improving ER+ bone metastatic breast cancer outcomes through metabolic re-programming of the microenvironment

KATHERINE LOREE COOK, PhD

Wake Forest University

Dietary Considerations Effecting Lung Metastatic Therapeutic Responsiveness and Co-Morbidities

IAN CORBIN, PhD

University of Texas Southwestern Medical Center

Lipoprotein Omega-3 Fatty Acid Nanoparticles: A Novel Treatment for Breast Cancer Liver Metastases

Massimo Cristofanilli, MD

Northwestern University

Presented In Memory of Karen Presswood, Co-Founder of METAvivor

Unravelling New Cytokine-Mediated Mechanisms to Enhance Response to CDK4/6 inhibition in ER+/HER2-Metastatic Breast Cancer